Long Position on VASC @ $38.35 on 5/31/2016 (Momentum)

Vascular Solutions, Inc. (VASC) provides clinical solutions for treating coronary and peripheral vascular disease worldwide.

The company’s primary products include GuideLiner guide extension catheter device for use in complex interventions; Pronto extraction catheters for treating acute myocardial infarction; vein catheter reprocessing service for the radiofrequency vein ablation catheter; and micro-introducer kits that are used to gain percutaneous access to the vasculature to perform minimally invasive procedures.

Its products also comprise hemostatic patches consisting of blood clotting products, such as the D-Stat Dry hemostat, a topical thrombin-based pad with a bandage used to control surface bleeding; radial access products, including the Accumed wrist positioning splints and Vasc Band inflatable compression bands; Langston catheter used for the measurement of intravascular pressure gradients, primarily to diagnose aortic valve stenosis; and D-Stat Flowable hemostat that is used to control active bleeding.

The company sells its products through direct sales force and distributor to interventional cardiologists, interventional radiologists, electrophysiologists, and vein specialists.

Shares are heading higher in an "upward trading channel" as shown in blue. They are currently sitting at the lower boundary of the said channel. The firm reported its earnings on April 27th. The company said it expects revenue in the range of $40.5 million to $41.5 million for the fiscal second quarter. It expects full-year earnings in the range of $1.19 to $1.23 per share, with revenue ranging from $163 million to $166 million. 

This is a low volume stock. Be sure to use a "Limit Order" and not a "Market Order."

52-Weeks Trading Range: $24.34 - $40.33

Entry Point: $38.35

Stop Loss: $36.43

Target Prce: $42.19

Updates

7/7/2016 11:21:22 AM

VASC closed at $42.20

Position closed on 7/7/2016 at price of $42.20 with a 10.04% gain in 37 days.

Back to Portfolio